Last reviewed · How we verify
AZD4076
At a glance
| Generic name | AZD4076 |
|---|---|
| Also known as | Study drug |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects (PHASE1)
- AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |